Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706056 · ClinicalTrials.gov registry record
A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 85
- Enrollment target
NCT00706056: Completed study, sponsored by Weill Medical College of Cornell University.
NCT00706056 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00706056 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
Study Summary
The objective of this study is to determine whether systemic blood pressure in the body is related to the development and progression of normal tension glaucoma in the eye. The study aims to clarify whether subjects with episodes of hypotension (low blood pressure) at night are at increased risk for sight loss and the development of normal tension glaucoma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-09 |
What the finished NCT00706056 record still lists
NCT00706056 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 85 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00706056 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00706056 about?
NCT00706056 is a clinical study titled "A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure". The objective of this study is to determine whether systemic blood pressure in the body is related to the development and progression of normal tension glaucoma in the eye. The study aims to clarify whether subjects with episodes of hypotension (low blood pressure) at night are at increased risk for...
What is the current status of trial NCT00706056?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2008-09. Estimated completion is 2011-09.
Who is sponsoring clinical trial NCT00706056?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia